학술논문
Efficacy and safety of PCSK9 inhibition with evolocumab in reducing cardiovascular events in patients with metabolic syndrome receiving statin therapy: Secondary analysis from the FOURIER randomized clinical trial
Document Type
Article
Author
Source
In: JAMA Cardiology . (JAMA Cardiology, February 2021, 6(2):139-147)
Subject
Language
English
ISSN
23806591
23806583
23806583